Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | biotin carboxylase subunit of acetyl CoA carboxylase, putative | 0.6091 | 0.6864 | 1 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.2687 | 0.251 | 0.2276 |
Trypanosoma brucei | 3-methylcrotonoyl-CoA carboxylase beta subunit, putative | 0.1141 | 0.0532 | 0.0541 |
Trypanosoma cruzi | 3-methylcrotonoyl-CoA carboxylase beta subunit, putative | 0.1141 | 0.0532 | 0.0927 |
Trypanosoma cruzi | 3-methylcrotonyl-CoA carboxylase, putative | 0.3206 | 0.3174 | 0.5531 |
Schistosoma mansoni | memapsin-2 (A01 family) | 0.3607 | 0.3688 | 0.3748 |
Mycobacterium ulcerans | acetyl-/propionyl-coenzyme a carboxylase alpha chain AccA1 | 0.3206 | 0.3174 | 1 |
Loa Loa (eye worm) | carboxyl transferase domain-containing protein | 0.8122 | 0.9463 | 0.9792 |
Mycobacterium tuberculosis | Probable pyruvate carboxylase Pca (pyruvic carboxylase) | 0.3206 | 0.3174 | 1 |
Echinococcus granulosus | propionyl coenzyme A carboxylase beta chain | 0.1141 | 0.0532 | 0.0236 |
Trypanosoma brucei | acetyl-CoA carboxylase | 0.8416 | 0.984 | 1 |
Brugia malayi | MAP kinase sur-1 | 0.2687 | 0.251 | 0.2276 |
Schistosoma mansoni | methylcrotonyl-CoA carboxylase | 0.3206 | 0.3174 | 0.3226 |
Mycobacterium ulcerans | acetyl-/propionyl-coenzyme a carboxylase alpha chain, AccA2 | 0.3206 | 0.3174 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.2687 | 0.251 | 0.2276 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.2687 | 0.251 | 0.4375 |
Leishmania major | propionyl-coa carboxylase beta chain, putative | 0.1141 | 0.0532 | 0.0541 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.2687 | 0.251 | 0.2551 |
Trypanosoma brucei | cAMP-specific phosphodiesterase | 0.0962 | 0.0303 | 0.0308 |
Toxoplasma gondii | acetyl-CoA carboxylase ACC1 | 0.8416 | 0.984 | 1 |
Plasmodium falciparum | biotin carboxylase subunit of acetyl CoA carboxylase, putative | 0.6091 | 0.6864 | 1 |
Echinococcus multilocularis | cAMP and cAMP inhibited cGMP 3',5' cyclic | 0.8542 | 1 | 1 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.2687 | 0.251 | 0.2551 |
Trypanosoma cruzi | acetyl-CoA carboxylase | 0.5211 | 0.5739 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.758 | 0.877 | 0.9051 |
Giardia lamblia | Kinase, CMGC MAPK | 0.2687 | 0.251 | 1 |
Mycobacterium ulcerans | pyruvate carboxylase | 0.3206 | 0.3174 | 1 |
Trypanosoma cruzi | cAMP specific phosphodiesterase, putative | 0.0962 | 0.0303 | 0.0529 |
Schistosoma mansoni | propionyl-CoA carboxylase beta chain mitochondrial precursor | 0.1141 | 0.0532 | 0.0541 |
Mycobacterium ulcerans | propionyl-CoA carboxylase beta chain 4 AccD4_2 | 0.1141 | 0.0532 | 0.1676 |
Leishmania major | acetyl-CoA carboxylase, putative | 0.8416 | 0.984 | 1 |
Echinococcus multilocularis | acetyl coenzyme A carboxylase 1 | 0.8416 | 0.984 | 0.9835 |
Mycobacterium ulcerans | propionyl-CoA carboxylase beta chain 4 AccD4 | 0.1141 | 0.0532 | 0.1676 |
Echinococcus multilocularis | propionyl coenzyme A carboxylase beta chain | 0.1141 | 0.0532 | 0.0236 |
Schistosoma mansoni | serine/threonine protein kinase | 0.2687 | 0.251 | 0.2551 |
Chlamydia trachomatis | biotin carboxylase | 0.2911 | 0.2797 | 1 |
Echinococcus granulosus | macrophage colony stimulating factor 1 receptor | 0.2161 | 0.1838 | 0.1582 |
Mycobacterium leprae | Probable bifunctional protein acetyl-/propionyl-coenzyme A carboxylase, alpha chain AccA3 (BccP) | 0.3206 | 0.3174 | 1 |
Schistosoma mansoni | pyruvate carboxylase | 0.3206 | 0.3174 | 0.3226 |
Schistosoma mansoni | camp/cgmp cyclic nucleotide phosphodiesterase | 0.0962 | 0.0303 | 0.0308 |
Toxoplasma gondii | acetyl-coA carboxylase ACC2 | 0.8416 | 0.984 | 1 |
Leishmania major | methylcrotonoyl-coa carboxylase biotinylated subunitprotein-like protein | 0.3206 | 0.3174 | 0.3226 |
Echinococcus multilocularis | propionyl coenzyme A carboxylase alpha chain | 0.3206 | 0.3174 | 0.2961 |
Brugia malayi | Carboxyl transferase domain containing protein | 0.8122 | 0.9463 | 0.9446 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2687 | 0.251 | 1 |
Mycobacterium tuberculosis | Probable acetyl-/propionyl-coenzyme A carboxylase alpha chain (alpha subunit) AccA2: biotin carboxylase + biotin carboxyl carrie | 0.3206 | 0.3174 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2687 | 0.251 | 1 |
Echinococcus granulosus | propionyl coenzyme A carboxylase alpha chain | 0.3206 | 0.3174 | 0.2961 |
Entamoeba histolytica | acetyl-coA carboxylase, putative | 0.1435 | 0.0909 | 0.5 |
Trypanosoma cruzi | cAMP specific phosphodiesterase, putative | 0.0962 | 0.0303 | 0.0529 |
Trypanosoma brucei | cAMP-specific phosphodiesterase | 0.0962 | 0.0303 | 0.0308 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.2687 | 0.251 | 0.4375 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.2687 | 0.251 | 0.2551 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.2687 | 0.251 | 0.2359 |
Trypanosoma brucei | 3-methylcrotonyl-CoA carboxylase alpha subunit, putative | 0.3206 | 0.3174 | 0.3226 |
Echinococcus granulosus | acetyl coenzyme A carboxylase 1 | 0.8416 | 0.984 | 0.9835 |
Trypanosoma brucei | unspecified product | 0.2108 | 0.1769 | 0.1798 |
Mycobacterium ulcerans | acetyl/propionyl CoA carboxylase subunit beta | 0.1141 | 0.0532 | 0.1676 |
Mycobacterium ulcerans | acetyl-/propionyl-CoA carboxylase subunit beta | 0.1141 | 0.0532 | 0.1676 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2687 | 0.251 | 1 |
Schistosoma mansoni | methylcrotonyl-CoA carboxylase | 0.3206 | 0.3174 | 0.3226 |
Wolbachia endosymbiont of Brugia malayi | Acetyl-CoA carboxylase, carboxyltransferase component | 0.1141 | 0.0532 | 0.1676 |
Mycobacterium ulcerans | acetyl-coenzyme a carboxylase carboxyl transferase (subunit beta) AccD3 | 0.1141 | 0.0532 | 0.1676 |
Mycobacterium ulcerans | propionyl-CoA carboxylase beta chain 5 AccD5 | 0.1141 | 0.0532 | 0.1676 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2687 | 0.251 | 1 |
Trypanosoma cruzi | 3-methylcrotonoyl-CoA carboxylase beta subunit, putative | 0.1141 | 0.0532 | 0.0927 |
Schistosoma mansoni | cgmp-dependent 35-cyclic phosphodiesterase | 0.0962 | 0.0303 | 0.0308 |
Trypanosoma cruzi | 3-methylcrotonyl-CoA carboxylase, putative | 0.3206 | 0.3174 | 0.5531 |
Loa Loa (eye worm) | hypothetical protein | 0.8274 | 0.9657 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.2687 | 0.251 | 0.2276 |
Schistosoma mansoni | acetyl-CoA carboxylase | 0.8416 | 0.984 | 1 |
Leishmania major | carboxylase, putative | 0.3206 | 0.3174 | 0.3226 |
Leishmania major | 3-methylcrotonoyl-CoA carboxylase beta subunit, putative | 0.1141 | 0.0532 | 0.0541 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.2687 | 0.251 | 0.2551 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.2687 | 0.251 | 0.4375 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.2687 | 0.251 | 0.4375 |
Trypanosoma brucei | 3-methylcrotonyl-CoA carboxylase alpha subunit, putative | 0.3206 | 0.3174 | 0.3226 |
Echinococcus granulosus | mitogen activated protein kinase | 0.2687 | 0.251 | 0.2276 |
Mycobacterium ulcerans | bifunctional protein acetyl-/propionyl-coenzyme a carboxylase (alpha chain) AccA3 | 0.3206 | 0.3174 | 1 |
Trypanosoma cruzi | cAMP specific phosphodiesterase, putative | 0.0962 | 0.0303 | 0.0529 |
Echinococcus granulosus | cAMP and cAMP inhibited cGMP 3'5' cyclic | 0.8542 | 1 | 1 |
Trypanosoma cruzi | acetyl-CoA carboxylase, putative | 0.1141 | 0.0532 | 0.0927 |
Toxoplasma gondii | pyruvate carboxylase | 0.3206 | 0.3174 | 0.3226 |
Wolbachia endosymbiont of Brugia malayi | Acetyl/propionyl-CoA carboxylase, alpha subunit | 0.3206 | 0.3174 | 1 |
Trypanosoma brucei | protein kinase, putative | 0.2687 | 0.251 | 0.2551 |
Toxoplasma gondii | acyl-CoA carboxyltransferase beta chain, putative | 0.1141 | 0.0532 | 0.0541 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.